Pharmaceuticals (ΜΚ2)
Lecturers: S. Gonos, Μ. Zervou, Α. Zifa, V. Zoubourlis, T. Calogeropoulou, D. Komiotis, G. Kontopidis, Μ.Koufaki, Ι. Kostas, D. Leonidas, K. Liadaki, T.Sarafidou, V. Skamnaki, G.Skrepas, G.Papadopoulos, Α.Pintzas
- Drug discovery and development process up to the drug market:
Target identification (Link disease and target/personalized targeted therapy)
Rational Drug design / in silico screening
medicinal chemistry / synthesis
Hit confirmation (screening assays)
Hit-to-Lead (SAR, potency, selectivity, PK/ADME-Tox)
Preclinical (Pharmacological profile, administration route, drug interactions) Clinical trials (Phases I, II, III)
- Biomedical technology
- cell (regenerative medicine)
- gene (genetic medicine/pharmacogenetics/personalized therapy)
- Molecular biotechnology (biopharmaceutical engineering)
- Computational biology/bioinformatics
Areas of focus include cancer, neurodegenerative diseases, cardiovascular, diabetes II, infectious diseases, ageing
 |
 |